date,title,source
Oct-18-18,"Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)",GlobeNewswire
Nov-08-18,Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update,GlobeNewswire
Nov-09-18,Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-19-18,"Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018",GlobeNewswire
Nov-20-18,"Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018",GlobeNewswire
Dec-12-18,Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-17-18,Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-19-18,Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't,American City Business Journals
Dec-20-18,"Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful?",Simply Wall St.
Jan-03-19,"Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE in San Francisco on Wednesday, January 9, 2019",GlobeNewswire
Feb-13-19,"Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019",GlobeNewswire
